Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Israel Daily Voice.
Press releases published on August 14, 2025
Undersea Warfare Systems Market Size Expected to Reach $24.8 Billion by 2031
EIN Presswire
·
August 14, 2025
Undersea warfare systems market was valued at $15.8 billion in 2021, and is estimated to reach $24.8 billion by 2031, growing at a CAGR of 4.7% WILMINGTON, DE, UNITED STATES, August 14, 2025 /EINPresswire.com/ -- By type, the weapon systems segment …
Remote Towers Market Size Expected to Reach $1,033.3 million by 2031
EIN Presswire
·
August 14, 2025
The remote towers market was valued at $318.7 million in 2021, and is estimated to reach $1,033.3 million by 2031, growing at a CAGR of 11.7% from 2022 to 2031. WILMINGTON, DE, UNITED STATES, August 14, 2025 /EINPresswire.com/ -- Global increase in …
Nasus Pharma Announces Closing of Initial Public Offering
GlobeNewswire
·
August 14, 2025
TEL AVIV, Israel, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Nasus Pharma Ltd. (NYSE: NSRX) (“Nasus Pharma” or the “Company”), a clinical-stage pharmaceutical company focused on the development of innovative intranasal products to treat emergency medical conditions …
LayerX Recognized as a Sample Vendor for Secure Enterprise Browser and AI Usage Control Categories in Multiple Gartner® Hype Cycle™ Reports
GlobeNewswire
·
August 14, 2025
NEW YORK, Aug. 14, 2025 (GLOBE NEWSWIRE) -- LayerX, the pioneer in browser-native security and AI usage control, today announced its recognition as a Sample Vendor in both the Secure Enterprise Browser (SEB) and AI Usage Control (AUC) categories. LayerX …
Enlivex to Present 3-Month Topline Data from Phase IIa Moderate/Severe Knee Osteoarthritis Trial on August 18 Webinar
GlobeNewswire
·
August 14, 2025
Webinar to Review Results from Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study Evaluating Allocetra™ in Patients with Moderate to Severe Knee Osteoarthritis Nes-Ziona, Israel, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Enlivex Therapeutics Ltd. ( …
Polyrizon Regains Compliance with Nasdaq Listing Requirements
GlobeNewswire
·
August 14, 2025
Ra’anana, Israel, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (Nasdaq: PLRZ) (“Polyrizon” or the “Company”), a biotechnology company focusing on the development of intranasal products, today announced that it has received formal confirmation from the …
MediWound Reports Second Quarter 2025 Financial Results and Provides Corporate Update
GlobeNewswire
·
August 14, 2025
VALUE Phase III Trial of EscharEx® in Venous Leg Ulcers Continues to Enroll Patients NexoBrid® Manufacturing Expansion on Track; Full Operational Capacity Expected by Year-End 2025 Additional Strategic Research Collaborations Established with Essity and …